Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences: The FACIT Experience
The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
Abstract
Health-related quality of life (HRQOL) is an important endpoint in cancer clinical trials and in cancer treatment in general; however, the meaningfulness of HRQOL scores may not be apparent to clinicians or researchers. Minimally important differences (MIDs) can enhance the interpretability of HRQOL scores by identifying differences likely to be meaningful to patients and clinicians. This article’s objective is to describe and provide examples of approaches we have used to identify MIDs for instruments in the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. Distribution- and anchor-based approaches are described and illustrated. We also discuss the importance of assessing the appropriateness of anchors, and we provide suggestions for combining results into a single range of plausible MIDs. MIDs for FACIT instruments established to date are summarized, and general guidelines that can be used to estimate MIDs for other FACIT instruments are provided. Applications of MIDs in research are illustrated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCIDs for MBC and other cancer patients are 2-point differences on the FACT-G subscale scores and a 5-point difference on the FACT-G total score, which fall in the range of .3 to .5 SDs [55, 56].”
From Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancer (2020) · cites this paper as [55]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005 · cited 1×
“Many instruments now exist to measure HRQOL in a variety of patient populations and health-care delivery settings (MAPI Research Institute, 2004) including cancer (Aaronson et al., 1993; Cella et al., 1993).”
BackgroundJacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 1×
“…1991; Kazis, Anderson, & Meenan, 1989; Sloan et al., 2003), the standard error of measurement (SEM) (Wyrwich, Nienaber, Tierney, & Wolinsky, 1999; Wyrwich, Tierney, & Wolinsky, 1999), the responsiveness index (Guyatt, Walter, & Norman, 1987) and the reliable change index (Jacobson & Truax, 1991).”
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 3×
“At the core of the measurement system is the 27-item Functional Assessment of Cancer Therapy–General (FACT-General) (Cella et al., 1993), which measures four domains: Physical Well-Being (PWB, 7 items), Social/Family Well-Being (SWB, 7 items), Emotional Well-Being (EWB, 6 items), and Functional Well-Being (FWB, 7 item…”
BackgroundMethodJaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982 · cited 1×
“The most commonly used anchor-based approach in longitudinal studies utilizes global ratings of change (GRC; Crosby et al., 2003); a method that was developed by Jaeschke, Singer, and Guyatt (1989).”
Method(2019) · doi:10.1188/19.onf · Cited by 3,217
Wilson, I. B. (1995) · JAMA · doi:10.1001/jama.1995.03520250075037 · Cited by 3,027 · cited 1×
“The field of health-related quality of life (HRQOL) measurementhas gone through several phases of development; the first was defining and conceptualizing the term health-related quality of life (HRQOL; Cella, 1994; de Haes, 1988; Ferrell, Dow, Leigh, Ly, & Gulasekaram, 1995; Wilson & Cleary, 1995).”
BackgroundInterpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 2,961
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Research works printed but not linked: 6
- Cella, D., 2004, Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, Version 4.1
- Elashoff, J. D., 2000, nQuery Advisor
- MAPI Research Institute, 2004, Quality of Life Instrument Database (QOLID)
- Sloan, J., 2003, Journal of Cancer Integrative Medicine, 1, 41
- Yost, K. J., 2004, Estimating minimally important differences in the Functional Assessment of Cancer Therapy-Colorectal (FACT-C)
- Yost, K. J., Value in Health
Cited by
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., Mannel, R. S., Homesley, H. D., Fowler, J., Greer, B. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104390 · Cited by 2,404
Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.012 · Cited by 2,362
“It is strongly recommended to use multiple independent anchors and to examine and confirm responsiveness across multiple samples [22,25, 28 ,29,39,40].”
BackgroundPhysical activity for cancer survivors: meta-analysis of randomised controlled trials
Fong, D. Y. T., Ho, J. W. C., Hui, B. P. H., Lee, A. M., Macfarlane, D. J., Leung, S. S. K., Cerin, E., Chan, W. Y. Y., Leung, I. P. F., Lam, S. H. S., et al. (2012) · BMJ · doi:10.1136/bmj.e70 · Cited by 782
A point of minimal important difference (MID): a critique of terminology and methods
King, M. T. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.9 · Cited by 646
Yost, K. J., Eton, D. T., Garcia, S. F., & Cella, D. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.11.018 · Cited by 597
“Effect sizes for these estimates were computed by dividing the adjacent category score difference by the overall SD for the sample [11].”
MethodSelf-citation
Metadata
- Authors
- Yost, K. J., & Eton, D. T.
- Affiliations
- Northwestern University (US)
- Venue
- Evaluation & the Health Professions
- Publisher
- SAGE Publications
- Published
- 2005-06
- Volume
- 28
- Issue
- 2
- Pages
- 172-191
- ISSN
- 0163-2787 (ISSN-L)
- 1552-3918
- OpenAlex
- W1979608435
- Cited by
- 382
- References
- 35
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 18 · 2023: 19 · 2022: 32 · 2021: 28 · 2020: 27 · 2019: 26 · 2018: 18 · 2017: 16 · 2016: 27 · 2015: 16 · 2014: 20 · 2013: 23 · 2012: 19
- FWCI
- 19.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Evaluation & the Health Professions (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r29ca051926-01a1, n01pc35136-24-0-2)
- Agency for Healthcare Research and Quality (R01HS09869)
- National Cancer Institute (CA-49883, U10CA049883, U10CA066636, CA-23318, N01PC35136, CA17145, CA-32102, CA61679, CA13650, CA49957, U10CA016116, U10CA017145, CA66636, CA-16116, U10CA032102, U10CA013650, U10CA049957, R01CA061679, U10CA023318, U10CA021115, CA51926, CA 21115)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- minimally important difference, health-related quality of life, FACIT, cancer clinical trials, cancer therapy, patient-reported outcomes
- MeSH terms
- Cross-Sectional Studies, Health Status Indicators, Humans, Neoplasms, Psychometrics, Quality of Life, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences: The FACIT Experience. https://app.cochat.ai/papers/10.1177/0163278705275340
- The paper
- Yost, K. J., & Eton, D. T. (2005). Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences: The FACIT Experience. Evaluation & the Health Professions. https://doi.org/10.1177/0163278705275340
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.